A role for fibroblast growth factor in liver regeneration has recently
been suggested, In this study we followed the intravenous delivery of
recombinant human [I-125]basic fibroblast growth factor to the liver
of rats following 68% partial hepatectomy, The concentration of [I-125
]basic fibroblast growth factor was higher in the liver (mean+/-SD, 6.
8+/-0.8 9% of injected dose) and the kidney (6.7+/-0.2%) of sham-opera
ted rats than in the spleen (2.8+/-0.45%). It increased threefold in t
he liver only, soon after 68% partial hepatectomy (20.3+/-5.3%, p<0.00
1), and remained high for the first 24 h. We also studied the effect o
f basic fibroblast growth factor injection on the rate of [H-3]thymidi
ne incorporation into liver DNA in rats subjected to either 21% or 68%
partial hepatectomy. A significant increase was seen after intramesen
teric injection of 500 ng basic fibroblast growth factor into rats sub
jected to 21% partial hepatectomy (23.5+/-7.3 cpm/mu g DNA) compared t
o saline-injected rats (14.5+/-6.4 cpm/mu g DNA, p=0.034). A dose of 5
000-25000 ng injected into a peripheral vein resulted in higher thymid
ine incorporation than in saline-injected control rats (36.9+/-12.7 an
d 9.7+/-6.1 cpm/mu g DNA, respectively; p<0.0001). No significant effe
ct was seen after 68% partial hepatectomy, Autoradiography showed that
the hepatocytes were the predominant labelled cells early after hepat
ectomy and basic fibroblast growth factor injection, We conclude that
basic fibroblast growth factor uptake by the liver is increased after
68% partial hepatectomy and that basic fibroblast growth factor is mit
ogenic to liver parenchymal cells early after 21% partial hepatectomy.